BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 28063200)

  • 1. Effects of 1,25(OH)
    Ding Y; Liao W; He XJ; Xiang W
    J Cell Mol Med; 2017 May; 21(5):975-985. PubMed ID: 28063200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCδ/ERK Signaling Pathway.
    He XJ; Ding Y; Xiang W; Dang XQ
    Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-(OH)
    Liu D; Fang YX; Wu X; Tan W; Zhou W; Zhang Y; Liu YQ; Li GQ
    Cell Commun Signal; 2019 Dec; 17(1):163. PubMed ID: 31823770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
    Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
    Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
    Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells.
    Banica LM; Besliu AN; Pistol GC; Stavaru C; Vlad V; Predeteanu D; Ionescu R; Stefanescu M; Matache C
    Int J Rheum Dis; 2016 Dec; 19(12):1294-1303. PubMed ID: 25351606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
    Shimp SK; Chafin CB; Regna NL; Hammond SE; Read MA; Caudell DL; Rylander M; Reilly CM
    Cell Mol Immunol; 2012 May; 9(3):255-66. PubMed ID: 22543833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.
    Ugarte-Gil MF; Sánchez-Zúñiga C; Gamboa-Cárdenas RV; Aliaga-Zamudio M; Zevallos F; Tineo-Pozo G; Cucho-Venegas JM; Mosqueira-Riveros A; Medina M; Perich-Campos RA; Alfaro-Lozano JL; Rodriguez-Bellido Z; Alarcón GS; Pastor-Asurza CA
    Lupus; 2016 Mar; 25(3):233-40. PubMed ID: 26385221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
    Healy KD; Zella JB; Prahl JM; DeLuca HF
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
    Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
    Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4+ T cells.
    Kongsbak M; von Essen MR; Boding L; Levring TB; Schjerling P; Lauritsen JP; Woetmann A; Ødum N; Bonefeld CM; Geisler C
    PLoS One; 2014; 9(5):e96695. PubMed ID: 24792400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and estrogen synergy in Vdr-expressing CD4(+) T cells is essential to induce Helios(+)FoxP3(+) T cells and prevent autoimmune demyelinating disease.
    Spanier JA; Nashold FE; Mayne CG; Nelson CD; Hayes CE
    J Neuroimmunol; 2015 Sep; 286():48-58. PubMed ID: 26298324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor expression in SLE peripheral blood CD4+T cells is associated with disease activity and cell apoptosis.
    Zhang Y; Niu L; Wang F; Tang X; Wang C; Zhu Y
    Mod Rheumatol; 2022 Apr; 32(3):577-583. PubMed ID: 34897495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
    Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
    Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamine-fas interactions: inhibition of polyamine biosynthesis in MRL-lpr/lpr mice is associated with the up-regulation of fas mRNA in thymocytes.
    Hsu HC; Thomas T; Sigal LH; Thomas TJ
    Autoimmunity; 1999; 29(4):299-309. PubMed ID: 10433086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship of vitamin D endocrine system and estrogen receptor expression with bone mineral density in initial systemic lupus erythematosus].
    Zheng YJ; Chen S; Li ZQ; Yuan M; Ao W; Bao CD; Hu DW
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):309-12. PubMed ID: 20627037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
    Apelgren LD; Bailey DL; Fouts RL; Short L; Bryan N; Evans GF; Sandusky GE; Zuckerman SH; Glasebrook A; Bumol TF
    Cell Immunol; 1996 Oct; 173(1):55-63. PubMed ID: 8871601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.